Skip to main content

Table 2 Lacrimal gland gene expression elevated by treatment of mice with LTBR-Ig compared to control

From: Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome

 

Gene

Fold Change Up

Spt2

salivary protein 2

116.39

Ren1

renin 1 structural

108.03

Crisp3

cysteine-rich secretory protein 3

88.55

Klk1b26

kallikrein 1-related petidase b26

83.06

Klk1b16

kallikrein 1-related peptidase b16

71.72

Abpb

androgen binding protein beta

51.14

Klk1b5

kallikrein 1-related peptidase b5

43.58

Klk1b9

kallikrein 1-related peptidase b9

42.18

Klk1b4

kallikrein 1-related pepidase b4

31.05

Klk1b8

kallikrein 1-related peptidase b8

30.37

Klk1b3

kallikrein 1-related peptidase b3

30.26

Muc10

mucin 10, submandibular gland salivary mucin

26.56

Egfbp2

epidermal growth factor binding protein type B

23.63

Klk1b4

kallikrein 1-related pepidase b4

18.95

Klk1b1

kallikrein 1-related peptidase b1

18.63

Smr2

submaxillary gland androgen regulated protein 2

15.83

Klk1b27

kallikrein 1-related peptidase b27

15.45

Klk1b21

kallikrein 1-related peptidase b21

14.58

Abpa

androgen binding protein alpha

9.94

Ngfb

nerve growth factor, beta

9.06

Klk1b24

kallikrein 1-related peptidase b24

8.59

Egf

epidermal growth factor

5.92

Klk1b11

kallikrein 1-related peptidase b11

5.29